Yahoo
NasdaqGS - Delayed Quote USD

Zenas BioPharma, Inc. (ZBIO)

32.88 -0.04 (-0.12%)
At close: September 4 at 4:00:00 PM EDT
32.88 0.00 (0.00%)
After hours: September 4 at 7:30:03 PM EDT
Trade ZBIO on Coinbase
Chart Range Bar
Loading chart for ZBIO
  • Previous Close 32.92
  • Open 32.66
  • Bid 23.64 x 200
  • Ask 41.72 x 200
  • Day's Range 32.38 - 33.29
  • 52 Week Range 13.50 - 44.60
  • Volume 452,688
  • Avg. Volume 853,520
  • Market Cap (intraday) 2.143B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -9.63
  • Earnings Date (est.) Nov 12, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 47.00

Zenas BioPharma, Inc., a clinical-stage biopharma company, engages in the development and commercialization of transformative immunology-based therapies. Its lead product candidate is obexelimab, a bifunctional monoclonal antibody designed to bind CD19 and Fc?RIIb for the treatment of various I&I diseases and various indications, including immunoglobulin G4-related disease, multiple sclerosis, and systemic lupus erythematosus. The company develops ZB002, an anti-TNFa monoclonal antibody; ZB004, a CTLA-4-Ig fusion protein designed to have an extended half-life versus; and ZB001, an anti-IGF-1R monoclonal antibody. The company was formerly known as Zenas BioPharma (Cayman) Limited and changed its name to Zenas BioPharma, Inc. in August 2023. The company was incorporated in 2019 and is headquartered in Waltham, Massachusetts.

zenasbio.com

167

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ZBIO
9.45%
S&P 500 (^GSPC)
12.75%

1-Year Return

ZBIO
93.64%
S&P 500 (^GSPC)
18.71%

3-Year Return

ZBIO
79.18%
S&P 500 (^GSPC)
70.93%

5-Year Return

ZBIO
79.18%
S&P 500 (^GSPC)
70.18%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue --
Earnings -80.99M
Profit Margin 0.00%

Q3

FY25

Q4

FY25

Q1

FY26

-200M
-150M
-100M
-50M
0
0.0%

Analyst Insights

View More

Analyst Price Targets

32.00
47.00 Average
32.88 Current
59.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/14/2026
Analyst Morgan Stanley
Rating Action Maintains
Rating Equal-Weight
Price Action Raises
Price Target 22 -> 32

Statistics

View More

Valuation Measures

Annual
As of 3/20/2026
  • Market Cap

    2.16B

  • Enterprise Value

    1.81B

  • Trailing P/E

    1.62

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.77k

  • Price/Book (mrq)

    8.74

  • Enterprise Value/Revenue

    1.81k

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -34.42%

  • Return on Equity (ttm)

    -199.04%

  • Revenue (ttm)

    1M

  • Net Income Avi to Common (ttm)

    -484.38M

  • Diluted EPS (ttm)

    -9.63

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    643.13M

  • Total Debt/Equity (mrq)

    120.54%

  • Levered Free Cash Flow (ttm)

    -211.39M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Research Reports

View More
  • Daily – Vickers Top Insider Picks for 04/01/2026

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 03/31/2026

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 03/30/2026

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 03/27/2026

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: